Abstract
In the context of psychopharmacotherapy, diagnostic instruments have always played a prominent role, in order either to assist the classification of a patient or to measure the degree of severity of psychopathological syndromes at a given stage as well as during the course of the disorder. In both these cases, but also in connection with other clinical areas, rating scales and diagnostic interviews are the instruments most frequently applied. A rating scale is generally understood to be an assessment scale. A distinction is made between self- and observer-rating scales. A self-rating scale is a procedure where the entire assessment process lies in the hands of the patient. By contrast, with an observer-rating scale the assessment process is conducted by independent examiners who include their own (or those of third parties) as well as the patient’s observations in their final assessment. Rating scales serve above all to record the severity of the psychopathology and side effects. In studies, especially observer-rating scales are the most important outcome criteria. However, the use of interviews and rating scales requires a comprehensive training.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res. 1990;3:247–51.
Adli M, Berghöfer A, Linden M, Helmchen H, Müller-Oerlinghausen B, Mackert A, Stamm T. Bauer, M. Effectiveness and feasibility of a standardized stepwise drug treatment regimen algorithm for inpatients with depressive disorders: Results of a 2-year observational algorithm study. J Cin Psychiatry; 2002;63:782–790.
Aitken RCB. Measuring of feelings using analogue scales. Proc R Soc Med. 1969;62:989–993.
AMDP, CIPS. Rating scales for psychiatry. Weinheim: Beltz; 1990.
Andreasen NC. Scale for the assessment of negative symptoms (SANS). Iowa City: University of Iowa; 1981.
Andreasen NC. Scale for the assessment of positive symptoms (SAPS). Iowa City: University of Iowa; 1984.
Andreasen NC, Carpenter WT, Kane JM, et al. Remission in schizophrenia: proposed criteria and rational for consens. Am J Psychiatry. 2005;162:441–9.
Angst J, Bech P, Boyer P, Bruinvels J, Engel R, Helmchen H, Hippius H, Lingjaerde O, Racagni G, Saletu B, Sedvall G, Silverstone JT, Stefanis CN, Stoll K, Woggon B. Consensus conference on the methodology of clinical trials of antidepressants, Zurich, march 1988: report of the consensus committee. Pharmacopsychiat. 1989;22:3–7.
Angst J, Bech P, Bobon D, Engel R, Hippius H, Janzen GJ, Lecrubier Y, Lingjaerde O, Möller HJ, Montgomery SA, Paes de Sousa M, Rossi A, Saletu B, Sedvall G, Stefanis C, Stoll KD, Woggon B. Report on the third consensus conference on the methodology of clinical trials with antipsychotic drugs. Pharmacopsychiat. 1991;24:149–52.
Angst J, Bech P, Bruinvels J, Engel RR, Ferner U, Guelfi JD, Lingjaerde O, Müller-Oerlinghausen B, Paes de Sousa M, Paykel E, Rimon R, Rzewuska M, Saletu B, Spiegel R, Stassen HH, Stoll KD, Wiesel FA, Woggon B, Zvolsky P. Report on the fifth consensus conference: methodology of long-term clinical trials in psychiatry. Pharmacopsychiat. 1994;27:101–7.
Antony MM, Barlow DH, editors. Handbook of assessment and treatment planning for psychological disorders. 2nd ed. New York: Guilford; 2010.
Ayearst LE, Bagby RM. Evaluating the psychometric properties of psychological measures. In: Antony MM, Barlow DH, editors. Handbook of assessment and treatment planning for psychological disorders. 2nd ed. New York: Guilford; 2010. p. 23–61.
Ballenger JC. Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatry. 1999;50(suppl 22):29–34.
Barnes TR. The Barnes akathisia rating scale – revisited. J Psychopharmacol. 2003;17:365–70.
Barnett JH, Eobbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD. Assessing cognitive function in clinical trials of schizophrenia. Neurosci Biobehav R. 2010;34:1161–77.
Bech P. Rating scales for psychopathology, health status and quality of life. Berlin: Springer; 1993.
Bech P, Rafaelsen OJ. The melancholia scale: development, consistency, validity and utility. In: Sartorius N, Ban TA, editors. Assessment of depression. Berlin: Springer; 1986. p. 259–69.
Bech P, Rafaelsen OJ, Kramp P, Bolwig TG. The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology. 1978;17:430–1.
Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the major depression inventory, using the present state examination as the index of diagnostic validity. J Affect Dis. 2001;66:159–64.
Beck AT, Steer RA. Beck anxiety inventory manual. San Antonio: The Psychological Corporation; 1993.
Beck AT, Steer RA, Brown GK. Beck depression inventory-II (BDI-II). San Antonio: Psychological Corporation; 1996.
Broome MR, Bottlender R, Rösler M, Stieglitz RD. The AMDP system. Manual for the assessment and documentation of psychopathology in psychiatry 9th ed. Göttingen: Hogrefe; 2018.
Brown TA, Barlow DH. Anxiety and related disorders interview schedule for DSM-5 (ADIS-5) – adult version. New York: Oxford University Press; 2014.
Chambless DL, Caputo GC, Bright P, Gallagher R. Assessment of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognition questionnaire. J Consult Clin Psychol. 1984;52:1090–7.
Chambless DL, Caputo GC, Jasin FE, Gracley EJ, Williams C. The mobility inventory for agoraphobia. Behav Res Ther. 1985;23:35–44.
Chouinard G, Margolese HC. Manual for the extrapyramidal symptom rating scale (ESRS). Schizophr Res. 2005;76:247–65.
Clayton AH. Recognition and assessment of sexual dysfunction associated with depression. J Clin Psychiatry. 2001;62(Suppl 3):5–9.
Clayton AH, McGarvey EL, Clavet GJ. The changes in sexual functioning questionnaire (CSFQ): development, reliability, and validity. Psychopharmacol Bull. 1997;33:731–45.
Conner KM, Davidson JRT, Churchill LE, Sherwood A, Foa E, Weisler RH. Psychomatric properties of the social phobia inventory (SPIN): a new self-rating scale. Br J Psychiatry. 2000;176:379–86.
Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edingurgh postnatal depression scale. Br J Psychiatry. 1987;150:782–6.
Day JC, Wood G, Dewey M, Bentall RP. A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry. 1995;166:650–3.
Derogatis LR. SCL-90-R, administration, scoring & procedures manual-II for the R(evised) version and other instruments of the psychopathology rating scales series. Towson: Clinical Psychometric Research; 1994.
Derogatis LR. The Derogatis interview for sexual functioning (DISF/DISF-SR): an introductory report. J Sex Marital Ther. 1997;23:291–304.
First MB, Williams JBW, Karg RS, Spitzer RL. Structured clinical interview for DSM-5© disorders – clinical version (SCID-5-CV). Washington, DC: American Psychiatric Association; 2016a.
First MB, Williams JBW, Smith Benjamin L, Spitzer RL. Structured clinical interview for DSM-5© disorders – personality disorders (SCID-5-PD). Washington, DC: American Psychiatric Association; 2016b.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS. The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability. Arch Gen Psychiatr. 1989;46:1006–11.
Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50–5.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62.
Harnisch S, Schade-Brittinger S, Rief W. Assessing adverse reactions in clinical trials [Deutsch]. Dtsch Med Wochenschr. 2012;137:1421–5.
Hawley C, Fineberg N, Roberts A, Baldwin D, Sahadevan A, Sharman V. The use of the Simpson Angus scale for the assessment of movement disorder: a training guide. Int J Psychiatry Clin Pract. 2003;7:349–2257.
Honigfeld G, Gillis RD, Klett JC. NOSIE. Nurses‘ observation scale for inpatient evaluation. In: Guy W, editor. ECDEU assessment manual for psychopharmacology (rev.ed.). Rockville: National Institute of Mental Health; 1976. p. 265–73.
Hunsley J, Mash EJ. Evidence-based assessment. Ann Rev Clin Psychol. 2007;3:29–51.
Inada T, Yagi G, Gardos G. Inter-rater reliability and the drug-induced-extrapyramidal symptoms scale (DIEPSS). Eur Neuropsychopharmacol. 1996;6:62.
Inada T, Beasley CM Jr, Tanaka Y, Walker DJ. Extrapyramidal symptom profiles assessed with the drug-induced extrapyramidal symptom scale: comparison with western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol. Int Clin Psychopharmacol. 2003;18:39–48.
Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANNS) for schizophrenia. Schiz Bull. 1987;13:261–76.
Keefe R. Assessment scales in schizophrenia. London: Springer Health Care; 2012.
Kessler RC, Ustün TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004;13:93–121.
Knol W, Keijsers CJ, Jansen PA, van Marum RJ. Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research. J Clin Psychopharmacol. 2010;30:57–63.
Kobak KA, Engelhardt N, Williams JBW, Lipsitz JD. Rater training in multicenter clinicla trials: issues and recommendations. J Clin Psychopharmacol. 2004;24:113–7.
Kobak KA, Lipsitz JD, Williams JBW, Engelhardt N, Bellew KM. A new approach to rater training and certification in a multicenter clinical trial. J Clin Psychopharmacol. 2005;25:407–12.
Liebowitz MR. Social phobia. Mod Probl Pharmacopsychiatry. 1987;22:141–73.
Linden M. How to define, find and classify side effects in psychotherapy: from unwanted events to adverse treatment reactions. Clin Psychol Psychother. 2013;20:286–96.
Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl. 1987;334:1–100.
Lorr M, Klett JC. Inpatient multidimensional psychiatric scale (IMPS). Manual. Palo ALTO: Consulting Psychologists Press; 1967.
Mason BJ, Kocsis JH, Leon AC, et al. Measurement of severity and treatment response in dysthymia. Psychiatic Ann. 1993;23:625–31.
McGahuey CA, Gelenberg AJ, Laukes CA, Moreno FA, Delgado PL, McKnight KM, Manber R. The Arizona sexual experience scale (ASEX): reliability and validity. J Sex Marital Ther. 2000;26:25–40.
McNair DM, Lorr M, Droppleman LF. Manual for the profile of mood sates (POMS). San Diego: Educational Testing Services; 1971.
Möller HJ. Standard rating scales in psychiatry: methodological basis, their possibilities and limitations and description of important rating scales. World J Biol Psychiatry. 2009;10:6–26.
Montgomery SA, Åsberg M. A new depression rating scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–9.
O’Donavan C. Achieving and sustaining remission in depression and anxiety disorder: introduction. Can J Psychiatr. 2004;49(suppl. 1):5–9.
Ogles BM. Measuring change in psychotherapy research. In: Lambert MJ, editor. Handbook of psychotherapy and behavior change. 6th ed. New York: Wiley; 2013. p. 134–66.
Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P. The internal and external validity of the major depression inventory in measuring severity of depressive states. Psychol Med. 2003;33:351–6.
Østergaard SD, Bech P, Trivedi MH, Wisniewski SR, Rush AJ, Fava M. Brief, unidimensional melancholia rating scales are highly sensitive to the effect of citalopram and may be have biological validity: implications for the research domain criteria (RDoC). J Affect Dis. 2014;163:18–24.
Overall JE, Gorham DR. 047 BPRS. Brief psychiatric rating scale. In: Guy W, editor. ECDEU assessment manual for psychopharmacology (rev.ed.). Rockville: National Institute of Mental Health; 1976. p. 157–69.
Rush AJ, First MB, Blacker D. Handbook of psychiatric measures. 2nd ed. Washington, DC: American Psychiatric Association; 2010.
Schennach R, Obermeier M, Seemüller F, Jäger M, Schmauss M, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J, Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Riedel M, Möller HJ. Evaluating depressive symptoms in schizophrenia: a psychometric comparison of the Calgary depression scale for schizophrenia and the Hamilton depression rating scale. Psychopathology. 2012;45:276–85.
Sheehan DV. The anxiety disease. New York: Charles Scribner & Sons; 1983.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33.
Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl. 1970;212:11–9.
Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton pleasure scale. Br J Psychiatry. 1995;167:99–103.
Stieglitz RD. Multimodal assessment (including triangulation). In: Fernandez-Ballesteros R, editor. Encyclopedia of psychological assessment. London: Sage; 2003. p. 606–10.
Stieglitz RD, Haug A, Fähndrich E, Rösler M, Trabert W. Comprehensive psychopathological assessment based on the Association for Methodology and Documentation in Psychiatry, (AMDP) system: development. Methodological foundation, application in clinical routine, and research. Front Psych. 2017;8:45. https://doi.org/10.33389/fpsyt.2017.00045.
van Riezen H, Segal M. Comparative evaluation of rating scales for clinical psychopharmacology. Amsterdam: Elsevier; 1988; 1988
Ventura J, Lukoff D, Nuechterlein KH, Liberman RP, Green MF, Shaner A. Brief Psychiatric Rating Scale (BPRS) expanded version (4.0): scales, anchor points, and administration manual. Int J Methods Psych Res. 1993;3:227–43.
Wing JK, Babor T, Brugha T, Burke J, Cooper JE, Giel R, Jablenski A, Regier D, Sartorius N. SCAN. Schedules for clinical assessment in neuropsychiatry. Arch Gen Psychiatry. 1990;47:589–93.
Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429–35.
Zajecka J, Mitchell S, Fawcett J. Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush sexual inventory. Psychopharmacol Bull. 1997;33:755–60.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Stieglitz, RD., Volz, HP. (2022). Psychopathology: Rating Scales for the Assessment of Mental Status. In: Riederer, P., Laux, G., Nagatsu, T., Le, W., Riederer, C. (eds) NeuroPsychopharmacotherapy. Springer, Cham. https://doi.org/10.1007/978-3-030-62059-2_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-62059-2_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-62058-5
Online ISBN: 978-3-030-62059-2
eBook Packages: MedicineReference Module Medicine